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Abstract 
Acute respiratory distress syndrome (ARDS) is associated with high 
rates of mortality, which is directly attributed to the pulmonary inflammatory 
response then compromising gaseous exchange. This case study describes the 
successful management of a 63-year-old male with severe ARDS who 
received a strategy which involved the following interventions: Nasal High 
Flow Oxygen (NHFO) therapy, and prone positioning. It is thought that this 
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strategy improved the lung volume at end expiration to an extent that the 
patient was able to avoid both noninvasive (NIV) and invasive mechanical 
ventilation (MV) (and their known associated risks). There is limited evidence 
describing the use of NHF therapy in patients with ARDS. The use of prone 
positioning has been demonstrated to significantly improve 28-day mortality 
in patients with severe ARDS with a PaO2/FiO2< 150 mmHg. The authors 
acknowledge that until such time that controlled clinical trials considering the 
efficacy of strategy are conducted it would be premature to recommend it 
forall suchcases. The prone position is a promising therapy for patients with 
spontaneous ventilation with high-flow oxygen therapy; controlled and 
randomized studies should be done to demonstrate its safety and efficacy. 
 




Acute respiratory distress syndrome (ARDS), also known as an adult 
respiratory failure syndrome, is a life threating condition associated with 
antinflammatory response involving the lung parenchyma which significantly 
alters gas exchange decreasing PaO2. (Matthay et al., 2012). 
In 1967 Ashbaugh reported a mortality of 70% for patients with 
ARDS, however more current evidence suggests a rate of between 40 and 
50%.Some of the randomized controlled trials have reported a higher increase 
in survival rates for select patient groups; likely due to the emergence of 
therapeutic strategies including:  protective ventilation, the use of PEEP, the 
limitation of tidal volume, and fluid restriction (Matthay et al., 2012; Villar el 
al., 2014). 
At a pathophysiological level, ARDS is an acute diffuse inflammatory 
response, that generates the activation of macrophages and mobilization of 
pro-inflammatory cytokines; in particular, the alpha tumoral necrosis, 
interleukins, and pro-coagulant factors, which collectively then activate the 
waterfall of coagulation producing microthrombosis. Conversely, the 
complement is activated and there is migration of polymorphonuclear 
neutrophils from the capillaries to the intersticial tissue and the alveoli, which 
damages the tissue through reactive species of oxygen and proteases; this 
generates pulmonary edema which alters the gaseous exchange, increased 
physiological dead space, and decreased lung compliance (Lam et al., 2008; 
Smith et al., 2013; Capelozzi et al., 2008). 
ARDS may be classified according to the diagnostic criteria (Villar et 
al., 2011; Costa et al., 2013; Ranieri et al., 2012): 
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1) Acute onset within of a defined event within 7 days e.g. sepsis. 
2) Bilateral opacities consistent with pulmonary edema, which may be 
detected on CT or chest X Ray. 
3) Respiratory failure not completely explained by cardiac failure or fluid 
over load (requiring an objective study, e.g. echocardiography) to 
exclude hydrostatic edema. 
 
The severity of ARDS with PEEP or CPAP > 5 cmH2O is classified as 
follows: a PaO2/FiO2 of 200 to 300 mmHg (mild ARDS), 100 to 200 mmHg 
(moderate ARDS), and< 100 mmHg (severe ARDS). 
The characteristic signs and symptoms are: hypoxemic respiratory 
failure with progressive dyspnea, nasal flaring, and thoracoabdominal 
asynchrony. 
The principal characteristic of this syndrome is refractory hypoxemia 
whilst on conventional treatment, which may improve with the use of MV, 
NIV or NHFO. There is some debate regarding the preventative or curative 
use of these respective therapies (Jaber et al., 2010). However, most patients 
with moderate to acute ARDS will require either NIV or MV to maintain 
optimal levels of oxygenation. It has been recently hypothesized that either 
Volume and or Patient self-inflicted lung injury (VILI and p-SILI) may 
contribute to the adverse events seen with the high respiratory drive associated 
with ARDS (Mancebo, 2016). In addition, for those with ARDS and 
PaO2/FiO2of < 150 mmHg prone positioning has been seen to significantly 
reduce mortality. 
 
Nasal high flow oxygen therapy 
Oxygen therapy is the first treatment choice for patients with acute 
hypoxemic respiratory failure (type 1) (O´Driscoll, 2012). It is normally 
delivered through nasal cannula or a face mask with or without a reservoir; 
however, the oxygen flow through these devices is limited to <15 L/min.In 
addition, the supplied oxygen is often diluted with room air, due to the failure 
of the device to meet the patient’s required inspiratory demand (Kallstrom, 
2002).  This means that the higher the inspiratory demand, the higher the 
dilution, of note these gases are not heated or humidified. A patient with mild 
respiratory failure may benefit from low flow oxygen therapy; however, 
patients with moderate to severe respiratory failure may have an inspiratory 
demand from 30 to 120 L/min, necessitating the use of devices able to supply 
these demands. There are specialist nasal cannula which can provide oxygen 
therapy (from 21 to 100%) at flows of up to 60 L/min at optimal heat and 
humidity (relative humidity 95 to 100%, heated 31 to 37 °C); this therapy is 
known as Nasal High Flow Oxygen therapy (NHFO)(Pilar et al., 2014).  
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There is a substantial amount of favorable evidence about the use of 
NHFO therapy across all age groups: neonatal, infant, pediatric and patients. 
In recent years this therapy has been studied on adult patients, in multiple 
clinical scenarios, including but not limited to the following conditions: 
 Respiratory failure 
 Mechanical ventilation weaning strategy 
 Procedural sedation 
 Peri intubation 
 Acute respiratory distress syndrome 
 Acute cardiac failure 
 Chronic cardiac failure 
 Pre-intubation oxygenation 
 Obstructive sleep apnea 
 Chronic obstructive pulmonary disease (COPD). 
 
NHFO and ARDS 
The evidence regarding NHFO and ARDS is emerging and conflicting, 
and most is retrospective.  Messika and colleagues (2018), concluded that 
NHFO may be considered as first-line therapy in ARF. Roca and colleagues 
(2016) proposed that those at risk for ARDS, NHF may achieve success rates 
similar to those seen with NIV. There are collection of case series e.g Medina 
et al (2015) in which it was observed that NHFO was not beneficial for 
morbidity and mortality outcomes in patients with severe ARDS. In cases of 
mild to moderate hypoxemia, both NIV and NHFO have proven to be 
acceptable alternatives before committing to MV. 
 
Mechanisms of action 
NHFO has a series mechanisms of action that collectively may help to 
resolve the work of breathing and improve outcomes. 
 
Respiratory support: 
 Continuous dynamic positive airway pressure. NHFO generates a 
continuous dynamic pressure in the airway, which increases the 
residual functional capacity, decreases atelectasis, and improves the 
ventilation-perfusion pulmonary ratio (Parke et al., 2009). 
 Wash out of the anatomical dead space (Möller et al., 2015) 
 The deadspace washout is linearly related to the rate of delivered flow 
NHFO. Clearance of the nasal component of the anatomical dead-
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O2 delivery 
There is an opertunity to accurately titrate the FiO2 delivered to match 
the patients needs (Parke et al., 2011). 
 
Patient comfort 
Nasal gases - when heated and humidified, are better tolerated, 
especially at high flows which ensures compliance (Maggiore et al., 2014). 
 
Prone position 
Prone positioning was first described in the literature by Bryan and 
colleagues (1974), who highlighted a potential favorable impact upon 
pulmonary mechanics.  Piehl et al.(1976) then also reported a significant 
improvement in oxygenation.  A third study - by Douglas (1977) hypothesized 
on the benefits of the prone positioning for patients with ARDS. Despite the 
reported improvement described in these studies, none demonstrated statistical 
significance, consequently they have been often disregarded by the clinical 
community (Gattinoni et al., 2013).  
Then in 2013, a French multi-center study demonstrated, a significant 
benefit for mortality rates at 28 days:16% for prone positioning group (38/237 
patients) versus 32.8% (75/229 patients) in the control group (p < 0.0001). It 
must be noted that the included patients had PaO2/FiO2of < 150 mmHg and 
were managed with protective mechanical ventilation and neuromuscular 
agents (Guérin et al., 2013).  
 
Nasal High Flow Oxygen therapy and body positioning 
A Spanish study using NHFO therapy enrolling 20 healthy patients 
demonstrated an increase in the lung volume at the end of expiration (LVEE), 
and associated with changes in body position. This research demonstrated that 
in supine and prone positions an increase in the LVEE may be achieved, a 
decrease in the RR with no associated adverse effects were also seen. A more 
homogenous LVEE was also seen with electric impedance tomography (EIT), 
in prone position (Riera et al., 2012).  
As a result of these findings, the authors decided to employ a combined 
strategy of the prone positioning with NHFO therapy, with the aim of 
improving clinical outcomes for severe ARDS patients. 
 
Presenting the clinical case 
The authors present a case of a 63-year-old male patient, with a history 
of chronic smoking (35 packets per year), chronic alcoholism, with no other 
comorbid conditions. The patient presented at the hospital with respiratory 
distress, somnolence, asthenia, adynamia, fever, dry cough, arthralgias, 
myalgias, and a history ofrunny nose and sneezing for at least 7 days prior to 
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his admission. In the emergency department (ED) his respiratory rate (RR) 
was 40 to 45 breaths per minute, SpO2 68 to 87%, (on O2 through a face mask 
10 L/min). Nebulized salbutamol, ipratropium, and broad-spectrum antibiotics 
Ceftriaxone, noclinical improvement was seen. X-rays showed bilateral 
radiolucent pictures suggestive of generalized severe pneumonic process 
(image 3). 
The ABG on admission showed PaO2 49 mmHg, PCO2 of 40 mmHg, 
HCO3 of 27.3,pH of 7.44, (on O2 via face mask at 10 L/min). The FiO2 was 
calculated at between 40 and 60%, with which the PaO2/FiO2 was calculated 
at 85 mmHg for this patient, adapted to the altitude of 1,920 m above sea level 
at which the city of San Juan del Rio, Queretaro, is located. With a barometric 
pressure of 568 mmHg, the adjusted PaO2/FiO2 was determined at 63 mmHg 
with leukocytes 19 x 103, urea 143 mg/dl, and creatinine 1.46 mg/dl. An ICU 
assessment was requested 24 hours after his entry to the ED. Staff were 
informed that the patient was not intubated as there was no mechanical 
ventilator available during the patient’s stay in the ED. He was then transferred 
to the ICU, as soon as the ABG were assessed and a provisional diagnosis 
ARDS and non-exacerbation COPD was made There was no presence of 
purulent expectoration or acute respiratory acidosis; however, he presented 
with a tendency for metabolic alkalosis probably associated with a renal 
compensation post chronic respiratory acidosis. 
On admission to the ICU, he had RR 40, was agitated, with intercostal, 
subcostal, supraclavicular, and cervical retraction, ABG: PaO2 of 52 mmHg, 
PaCO2 of 52 mmHg, pH of 7.3, HCO3 of 23.1 mmol/L, and SaO2 of 82%.With 
a diagnosis of respiratory acidosis and severe ARDS, a ground-glass image 
was observed covering 3/4 of both lungs, bilateral air bronchogram and 
bilateral pleural effusion were also observed. 
 
Intervention 
With a diagnosis of a severe hypoxemic RF, hypercapnia, and 
respiratory acidosis, the decision was made to trial NHFO therapy at 60 L/min 
and an FiO2 at 100%. The respiratory WOB improved immediately with 
decreased RR to 35 and improved the SpO2from 82% to 92%. With informed 
consent from the patient he was placed in a decubital prone position. The 
patient was placed in prone position with the help of a physician, a nurse, and 
a hospital stretcher, and an abrupt improvement in SpO2 97% was shown and 
the RR decreased to 27.Hewas informed that he could move tolerated, but to 
always maintain the prone position.A comparative ABGwas taken an hour 
after the position change, which showed: pH 7.33, PaO2 60 mmHg, PaCO2 55 
mmHg, SaO2 89%, HCO3 25.8.The patient was placed under close 
surveillance and his respiratory mechanical pattern, heart rate, RR, urine 
output, and level of consciousness continued to remain stable. The patient 
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remained closely monitored with a view to proceed with an immediate 
intubation if. However, the patient’s condition continued to steadily improve 
with the NHFO and prone positioning strategy. Fluid restriction was 
commenced, in addition to the following medications: Oseltamivir 75 mg 
every 12 h, Levofloxacino 750 mg IV every 24 h, Ceftriaxone 2 g IV every 24 
h, metilprednisone IV 1 mg/kg every 24 h, glycemic control targeting 110 to 
180 mg/dl, Enoxaparina 1 mg/kg SC every 24 h, and Omeprazol 40 mg IV 
every 24 h. 
The patient was kept prone for 4 hours in a swimmer position, moving 
as tolerated exchanging the elevation of the left and right arms with head 
ipsilateral lateralization; later, the patient was returned to a semi-fowler 
position. Pulmonary physiotherapy and he remained closely monitored for any 
changes. The prone position was repeated the following days with the same 
scheme during the morning shift, in the afternoon and night shifts the patient 
remained in the semi-fowler position, alternating with decubital left and right 
lateral as tolerated, and a larger draining of secretions was observed with the 
pulmonary physiotherapy in prone position. We can see the progression of the 
patient during the ICU stay in the X-rays and tomography (image 2 and 3).  
 
Image 1. Prone position with high flow oxygen therapy. 
 
The patient showed bleeding from the nasogastric tube, and an 
endoscopy was performed, during which he received NHFO therapy without 
any complications. In order to exclude cardiac contributor to this acute event, 
a transthoracic echocardiogram was performed. Systolic cardiac failure was 
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not demonstrated, however the left ventricular ejection fraction was 62%, 
along with severe pulmonary arterial hypertension, and mild tricuspid failure. 
Sildenafil was commenced. 
The patient kept the prone position 4 hours each morning for 5 days. 
After that period, he was maintained in semi-fowler position with frequent 
mobilization, continued on NHFO therapy for 14 days. The NHFO FiO2 was 
titrated to a target SaO2>88% and absence of dyspnea, the flow was kept at 
between 60 and 40 L/min the first 12 days, during which the required FiO2 
approximately 60%.On two occasions the FiO2 was required to be increased 
to 100%.On day 12 in the ICU the flow was successfully reduced to 35 to 30 
L/min after 12 hours, and on the day 13 it was reduced to 25 to 20 L/min after 
12 hours and a decrease in the FiO2 from 40 to 30%.On day 14 the NHFO 
therapy was stopped, with a pulse-oximetry SpO2 of 95%, and the patient was 
given low-flow standard oxygen therapy without complications. He left the 
ICU 7 days after ceasing the NHF therapy, with no evidence of systemic 
inflammatory response, or organ dysfunction. The evolution in gasometrical 
parameters during his stay in the ICU is shown in image 4. 
 
Image 2. Anterior-posterior X-rays performed in portable way during the internment of the 
patient in the ICU that shows the radiographic evolution since the entry of the patient until 
his egress from the ICU. 
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1. Simple thorax computed tomography at the patient’s entry. 
 
 
2. Simple thorax tomography at day 10 of stay in the ICU, after high-flow oxygen therapy. 
 
Image 3. Anterior-posterior thorax simple tomography studies performed during the 
internment of the patient in the ICU that show the radiographic evolution since the entry of 
the patient until his egress from the ICU. 
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Image 4. pO2: Arterial partial oxygen pressure. pCO2: Arterial partial carbon dioxide 
pressure. FiO2: Inspired oxygen fraction. The graph shows the behavior of gas exchange 
during the patient’s evolution. The first two days he received oxygen through a reservoir 
mask and the oxygenation decrease is observed along with respiratory acidosis; later, the 
patient is treated with high-flow oxygen therapy and prone position, observing a transitory 
improvement until day 6, where an important oxygen increase takes place, with an upturn in 
PaO2 and less need of inspired oxygen fraction. 
 
Discussion 
ARDS is a severe disease with an associated high mortality, it has been 
observed that both prone positioning and NHFO therapy benefit this patient 
population in patients with ARDS with PaO2 / FiO2 <150 mmHg. In this case, 
four important factors described above and the fact that LVEE increases in 
prone position using NHF therapy as a result of the recruitment of alveolar 
units, the authors decided to test the management of patients with acute ARDS 
(unrelated to COPD) with therapy with UFH and prone position. During the 
treatment of the 63-year-old case, the patient was monitored closely to detect 
any signs of impairment in order to scale attention as needed. The 
improvements in ABG and SpO2 seen with NHFO therapy were only 
significant, however, when the prone position was also adopted, the patient's 
WOB improved even more. 
The patient and his relatives were kept informed of the practice 
strategy and understood to be a tool used with the objective of avoiding the 
need for mechanical ventilation. Of note and contrary to what has been 
previously described the PaCO2 did not decrease in response to prone position; 
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however, the PaO2 did increase, along with SaO2, the decrease of the 
respiratory rate, and an improvement in dyspnea. As it is widely recommended 
to monitor the patient closely while receiving noninvasive mechanical 
ventilation, especiallywithin1 to 2 hours after the commencement of the 
treatment, the medical and nursing staff performed close surveillance for 
symptoms and vital signs of the patient. Should his condition worsen, 
treatment would be switched to invasive mechanical ventilation immediately; 
however, the trends always showed improvement. 
The authors stress the fact that within the first 7 days of the high-flow 
oxygen therapy the possibility of delaying the invasive treatment was not 
discard or the patient deprived of the benefits of early mechanical ventilation. 
An evaluation was made in regard to the risk-benefit of limiting all the risks 
associated with the use of sedation, neuro-muscular blockage, opioid 
analgesia, and mechanical ventilation on its own. It was clearly understood 
that some patients with COPD can suffer complications with long-term 
mechanical ventilation, which is why the patient in this study was 
conservatively managed, which, in the end, showed the benefit of avoiding the 
use of mechanical ventilation. 
The high-flow oxygen therapy and prone position were sufficient to 
treat a case of severe ARDS, eliminating the need for using invasive 
mechanical ventilation. However, the authors cannot recommend their use for 
this level of severity in a routine manner, which is why controlled studies of 
selected comparative cases must be undertaken using invasive mechanical 
ventilation. The authors note that there is a clinical trial in progress 
ClinicalTrials.gov Identifier: NCT03095300. 
 
Conclusion 
The prone position is a strategy that has shown a significant decrease 
in mortality in patients with ARDS, and it is a promising therapy for patients 
with spontaneous ventilation with high-flow oxygen therapy and an alternative 
to avoid invasive mechanical ventilation; controlled and randomized studies 
should be done to demonstrate its safety and efficacy. 
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